Jasper Therapeutics Inc. – Filings and Transcripts

NASDAQ: JSPR
Share price (3/24/26): $1.15
Market cap (3/24/26): $32.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration

Amendment to registration of securities for employees

Ownership Filter

Integrated Core Strategies (US) LLC

Carlyle Group Inc (The)

The Goldman Sachs Group Inc.

Mahal Jeetinder Singh

News Filter

Reports Positive Updated Data From Briquilimab Studies in Chronic Spontaneous Urticaria

Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth

Reports Positive Preliminary Data From ETESIAN Study of Briquilimab in Asthma and Findings From BEACON Study Internal Investigation

Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Announces Pricing of $30 Million Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission